MGLRX | TGREX | MGLRX / TGREX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 13 years | 10 years | - |
Gain YTD | -0.062 | 2.155 | -3% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.27B | 40.4M | 5,611% |
Annual Yield % from dividends | 1.94 | 1.67 | 116% |
Returns for 1 year | 1.05 | 6.33 | 17% |
Returns for 3 years | -17.89 | -6.61 | 270% |
Returns for 5 years | -2.71 | 16.10 | -17% |
Returns for 10 years | 22.86 | 43.80 | 52% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ACVRX | 8.71 | 0.02 | +0.23% |
American Century International Val R | |||
LHCAX | 20.14 | N/A | N/A |
Lord Abbett Health Care A | |||
CEISX | 13.83 | N/A | N/A |
Manning & Napier Callodine Equity Inc S | |||
MCGCX | 18.76 | -0.05 | -0.27% |
BlackRock Advantage Global Investor C | |||
JLCVX | 74.26 | -0.37 | -0.50% |
JHancock Fundamental Large Cap Core R5 |